Vitreous Vascular Endothelial Growth Factor Concentrations in Proliferative Diabetic Retinopathy versus Proliferative Vitreoretinopathy

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Ophthalmic Research

• Publication date

  2011-06-21

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1159/000324200PMID 21691136
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A review of clinical trials of anti-VEGF agents for diabetic retinopathy

  2010cited by this paper
• Correlation between angiotensin-converting enzyme, vascular endothelial growth factor, and matrix metalloproteinase-9 in the vitreous of eyes with diabetic retinopathy

  2008cited by this paper
• A phase II randomized clinical trial of intravitreal bevacizumab for diabetic macular edema.

  2007cited by this paper
• Balance of Vascular Endothelial Growth Factor and Pigment Epithelial Growth Factor prior to Development of Proliferative Vitreoretinopathy

  2007cited by this paper
• Endothelial growth factors VEGF and bFGF differentially enhance monocyte and neutrophil recruitment to inflammation

  2006cited by this paper
• Correlation between angiotensin-converting enzyme, vascular endothelial growth factor, and matrix metalloproteinase-9 in the vitreous of eyes with diabetic retinopathy.

  2006cited by this paper
• Vitreous levels of angiopoietin 2 and vascular endothelial growth factor in patients with proliferative diabetic retinopathy.

  2005cited by this paper
• Vascular Endothelial Growth Factor Levels in Vitreous and Serum of Patients with either Proliferative Diabetic Retinopathy or Proliferative Vitreoretinopathy

  2005cited by this paper
• Vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor: implications for ocular angiogenesis.

  2004cited by this paper
• Differential expression of angioregulatory factors in normal and CNV-derived human retinal pigment epithelium

  2004cited by this paper
• Vascular endothelial growth factor and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives

  2003cited by this paper
• The role of fibroblast growth factors in vascular development.

  2002cited by this paper
• Arteriolar and venular patterning in retinas of mice selectively expressing VEGF isoforms.

  2002cited by this paper
• Unbalanced vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor in diabetic retinopathy.

  2002cited by this paper
• Glucose, VEGF-A, and diabetic complications.

  2001cited by this paper
• Vascular endothelial growth factor and vascular adjustments to perturbations in oxygen homeostasis.

  2001cited by this paper
• Vascular endothelial growth factor and basic fibroblast growth factor induce expression of CXCR4 on human endothelial cells: In vivo neovascularization induced by stromal-derived factor-1alpha.

  1999cited by this paper
• Vascular endothelial growth factor-induced migration of vascular smooth muscle cells in vitro.

  1999cited by this paper
• Detection of Vascular Endothelial Growth Factor and Tumor Necrosis Factor Alpha in Epiretinal Membranes of Proliferative Diabetic Retinopathy, Proliferative Vitreoretinopathy and Macular Pucker

  1998cited by this paper
• Vascular endothelial growth factor is present in glial cells of the retina and optic nerve of human subjects with nonproliferative diabetic retinopathy.

  1997cited by this paper
• Increased Vascular Endothelial Growth Factor Levels in the Vitreous of Eyes With Proliferative Diabetic Retinopathy

  1995cited by this paper
• Hypoxic regulation of vascular endothelial growth factor in retinal cells.

  1995cited by this paper
• Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model.

  1994cited by this paper
• Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy.

  1994cited by this paper
• An updated classification of retinal detachment with proliferative vitreoretinopathy.

  1991cited by this paper
• AN UPDATED CLASSIFICATION OF RETINAL DETACHMENT WITH PROLIFERATIVE VITREORETINOPATHY

  1991cited by this paper
• Proliferative vitreoretinopathy. The mechanism of development of vitreoretinal traction.

  1987cited by this paper
• Four risk factors for severe visual loss in diabetic retinopathy. The third report from the Diabetic Retinopathy Study. The Diabetic Retinopathy Study Research Group.

  1979cited by this paper

• Intracellular Signaling Pathways and Their Potential Targeting for Treatment of Ocular Posterior Segment Fibrosis

  2025cites this paper
• Intravitreal Injection of Bevacizumab for the Prevention of Postoperative Proliferative Vitreoretinopathy in High-Risk Patients Selected by Laser Flare Photometry

  2023cites this paper
• Vitreal Concentrations of Vascular Endothelial Growth Factor in Patients with Rhegmatogenous Retinal Detachment

  2023cites this paper
• Vitreous humor proteome: unraveling the molecular mechanisms underlying proliferative and neovascular vitreoretinal diseases

  2022cites this paper
• Changes in aqueous and vitreous inflammatory cytokine levels in proliferative diabetic retinopathy: a systematic review and meta-analysis

  2022cites this paper
• The Role of Intravitreal Anti-VEGF Agents in Rabbit Eye Model of Open-Globe Injury

  2021cites this paper
• Dysregulation of trophic factors contributes to diabetic retinopathy in the Ins2Akita mouse.

  2020cites this paper
• Molecular Surgery: Proteomics of a Rare Genetic Disease Gives Insight into Common Causes of Blindness

  2020cites this paper
• Melatonin regulates the expression of inflammatory cytokines, VEGF and apoptosis in diabetic retinopathy in rats.

  2020cites this paper
• Toward the Clinical Application of Therapeutic Angiogenesis Against Pediatric Ischemic Retinopathy

  2020cites this paper
• CHARACTERISTICS OF RETINAL DETACHMENT PATIENTS WITH PROLIFERATIVE VITREORETINOPATHY AT Dr. SOETOMO GENERAL ACADEMIC HOSPITAL

  2019cites this paper
• Anti-inflammatory cytokine and angiogenic factors levels in vitreous samples of diabetic retinopathy patients

  2018cites this paper
• Determining the effect of low-dose isotretinoin on proliferative vitreoretinopathy: the DELIVER trial

  2018cites this paper
• Adjunctive Pharmacological Therapies in the Management of Proliferative Vitreoretinopathy

  2018cites this paper
• EFFICACY OF INTRAVITREAL INJECTION OF BEVACIZUMAB IN VITRECTOMY FOR PATIENTS WITH PROLIFERATIVE VITREORETINOPATHY RETINAL DETACHMENT: A Meta-analysis of Prospective Studies

  2017cites this paper
• Increased levels of alphaB‐crystallin in vitreous fluid of patients with proliferative diabetic retinopathy and correlation with vascular endothelial growth factor

  2017cites this paper
• Cytokines and growth factors in the pathogenesis of proliferative diabetic retinopathy

  2017cites this paper
• PDGFs and their receptors.

  2017cites this paper
• Tumor necrosis factor-like weak inducer of apoptosis association with proliferative diabetic retinopathy and promotes proliferation and collagen synthesis in retinal ARPE-19 cells.

  2016cites this paper
• Intravitreal Injection of Bevacizumab in Primary Vitrectomy to Decrease the Rate of Retinal Redetachment: A Randomized Pilot Study

  2016influential citation
• Clinical,pathogeneticandprognosticvalueofdiabeticretinopathy's progressionafterphacoemulsificationinpatientswiththeessential hypertension

  2016cites this paper
• Клинико-патогенетическое и прогностическое значение факторов прогрессирования диабетической ретинопатии на фоне гипертонической болезни после факоэмульсификации

  2016cites this paper
• Proliferative and inflammatory factors in the vitreous of patients with proliferative diabetic retinopathy

  2015influential citation
• 15 – Diabetes Mellitus

  2015cites this paper
• IL-4, IL-6, IL-10, IL-17A and vascular endothelial growth factor in the vitreous of patients with proliferative diabetic retinopathy

  2014cites this paper
• Comment on ‘Intrasilicone oil injection of bevacizumab at the end of retinal reattachment surgery for severe proliferative vitreoretinopathy’

  2014cites this paper
• Translational vitreous proteomics

  2014influential citation
• Intrasilicone oil injection of bevacizumab at the end of retinal reattachment surgery for severe proliferative vitreoretinopathy

  2014cites this paper
• Bevacizumab inhibits proliferation of choroidal endothelial cells by regulation of the cell cycle

  2013influential citation
• Ranibizumab is a potential prophylaxis for proliferative vitreoretinopathy, a nonangiogenic blinding disease.

  2013cites this paper
• Defining the seriousness of proliferative vitreoretinopathy by aspiration of cytokines from the anterior chamber.

  2013cites this paper
• Proteomic Interactions in the Mouse Vitreous-Retina Complex

  2013cites this paper
• Pathophysiology Of Retina In Type Ii Diabetes Mellitus Conventional Diagnostic Parameters Versus Emerging Roles Of Growth Factors And Cytokines

  2012cites this paper